# Evaluation of the Effect of the "CR500 SINGLE-DOSE GEL" Medical Device in Patients With Knee Osteoarthritis (KOA)

> **NCT05661162** · NA · COMPLETED · sponsor: **Contrad Swiss SA** · enrollment: 38 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** CR 500™ SINGLE-DOSE GEL

## Key facts

- **NCT ID:** NCT05661162
- **Lead sponsor:** Contrad Swiss SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-17
- **Primary completion:** 2021-05-18
- **Final completion:** 2021-05-18
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05661162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05661162, "Evaluation of the Effect of the "CR500 SINGLE-DOSE GEL" Medical Device in Patients With Knee Osteoarthritis (KOA)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05661162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*